Yüklüyor......
Prostate cancer: endogenous chemical castration
We report treatment of intermediate risk prostate cancer in a patient with a brief period of androgen deprivation secondary to a pituitary adenoma. This was a patient with intermediate risk prostate cancer diagnosed in the setting of an elevated prostate-specific antigen (PSA). The patient subsequen...
Kaydedildi:
| Yayımlandı: | BMJ Case Rep |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMJ Publishing Group
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4854128/ https://ncbi.nlm.nih.gov/pubmed/27126094 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2016-214782 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|